查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2031048

全球銀屑病治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Psoriasis Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球乾癬治療市場預計將從2025年的312.4億美元成長至2034年的826.1億美元，2026年至2034年的複合年成長率（CAGR）為11.41%。隨著醫療保健系統越來越重視對影響生活品質的慢性自體免疫疾病的管理，該市場正在不斷發展。銀屑病是一種長期發炎性皮膚病，需要持續使用局部療法、全身性藥物和生物製藥來治療。人們對早期診斷和治療方案的認知不斷提高，有助於提升患者的治療參與。醫療保健提供者擴大採用針對潛在免疫反應而不是僅僅緩解症狀的先進治療方法，從而改善治療效果並實現長期疾病管理。

自體免疫疾病盛行率的上升、生物製藥研發的進步以及醫療保健成本的上漲是推動這一成長的主要因素。生物製藥和標靶治療因其在治療中重度乾癬方面的有效性而備受關注。製藥公司正大力投資研發，以開發更安全、更有效的治療方法。此外，皮膚科診所和遠端醫療服務的普及也提高了病患獲得醫療保健服務的便利性。部分地區優惠的報銷政策也促進了治療方案的推廣應用。

展望未來，個人化醫療和新一代生物製藥的持續創新備受期待。副作用較少、療效較佳的口服療法的研發將進一步提高病患的用藥依從性。在新興市場，醫療基礎設施的完善和公眾意識的提高預計將推動治療方法的普及。隨著研究的深入和治療選擇的不斷豐富，銀屑病治療市場預計將持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球銀屑病治療市場：依藥物類別分類

  • 市場分析、洞察與預測
  • TNF抑制劑
  • 白細胞介素抑制劑
  • 其他

第5章 全球銀屑病治療市場：按類型分類

  • 市場分析、洞察與預測
  • 斑塊型乾癬
  • 乾癬性關節炎
  • 其他

第6章 全球銀屑病治療市場：依產品類型分類

  • 市場分析、洞察與預測
  • 生物製劑
  • 非生物過程

第7章 全球銀屑病治療市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 口服
  • 腸外/全身給藥
  • 外用

第8章 全球銀屑病治療市場：按分銷管道分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球銀屑病治療市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • AbbVie Inc
    • Novartis AG
    • Johnson & Johnson ServicesInc
    • Pfizer Inc
    • LEO Pharma A/S
    • Merck & Co.Inc
    • Amgen Inc
    • Eli Lilly And Company
    • Evelo BiosciencesInc
    • UCB SA
    • Sun Pharmaceutical Industries Ltd
簡介目錄
Product Code: VMR112117972

The global psoriasis treatment market size is expected to reach USD 82.61 Billion in 2034 from USD 31.24 Billion in 2025, growing at a CAGR of 11.41 during 2026-2034.This market is evolving as healthcare systems place greater emphasis on managing chronic autoimmune conditions that affect quality of life. Psoriasis, a long-term inflammatory skin disorder, requires continuous treatment through topical therapies, systemic drugs, and biologics. Growing awareness about early diagnosis and treatment options is contributing to rising patient engagement. Healthcare providers are increasingly adopting advanced therapies that target underlying immune responses rather than just symptoms, improving treatment outcomes and long-term disease control.

Growth is supported by increasing prevalence of autoimmune diseases, advancements in biologic drug development, and rising healthcare expenditure. Biologics and targeted therapies are gaining prominence due to their effectiveness in managing moderate to severe psoriasis. Pharmaceutical companies are investing heavily in research to develop safer and more efficient treatments. Additionally, the expansion of dermatology clinics and telemedicine services is improving patient access to care. Favorable reimbursement policies in several regions are also encouraging treatment adoption.

Future prospects indicate continued innovation in personalized medicine and next-generation biologics. The development of oral therapies with fewer side effects and improved efficacy will further enhance patient compliance. Emerging markets are expected to witness increased adoption due to improving healthcare infrastructure and awareness. As research continues to advance and treatment options expand, the psoriasis treatment market is positioned for sustained growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Drug Class

  • TNF Inhibitors
  • Interleukins Inhibitors
  • Others

By Type

  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Others

By Product Type

  • Biologics
  • Non-Biologics

By Route of Administration

  • Oral
  • Parenteral/Systemic
  • Topical

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

COMPANIES PROFILED

  • AbbVie Inc., Novartis AG, Johnson & Johnson Services, Inc., Pfizer Inc., LEO Pharma A/S, Merck & Co., Inc., Amgen Inc., Eli Lilly and Company, Evelo Biosciences, Inc., UCB S.A., Sun Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PSORIASIS TREATMENT MARKET: BY DRUG CLASS 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Drug Class
  • 4.2. TNF Inhibitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Interleukins Inhibitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PSORIASIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Plaque Psoriasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Psoriatic Arthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PSORIASIS TREATMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Product Type
  • 6.2. Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Non-Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PSORIASIS TREATMENT MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Route Of Administration
  • 7.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Parenteral/Systemic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PSORIASIS TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Distribution Channel
  • 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PSORIASIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Drug Class
    • 9.2.2 By Type
    • 9.2.3 By Product Type
    • 9.2.4 By Route Of Administration
    • 9.2.5 By Distribution Channel
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Drug Class
    • 9.3.2 By Type
    • 9.3.3 By Product Type
    • 9.3.4 By Route Of Administration
    • 9.3.5 By Distribution Channel
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Drug Class
    • 9.4.2 By Type
    • 9.4.3 By Product Type
    • 9.4.4 By Route Of Administration
    • 9.4.5 By Distribution Channel
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Drug Class
    • 9.5.2 By Type
    • 9.5.3 By Product Type
    • 9.5.4 By Route Of Administration
    • 9.5.5 By Distribution Channel
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Drug Class
    • 9.6.2 By Type
    • 9.6.3 By Product Type
    • 9.6.4 By Route Of Administration
    • 9.6.5 By Distribution Channel
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PSORIASIS TREATMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 AbbVie Inc
    • 11.2.2 Novartis AG
    • 11.2.3 Johnson & Johnson ServicesInc
    • 11.2.4 Pfizer Inc
    • 11.2.5 LEO Pharma A/S
    • 11.2.6 Merck & Co.Inc
    • 11.2.7 Amgen Inc
    • 11.2.8 Eli Lilly And Company
    • 11.2.9 Evelo BiosciencesInc
    • 11.2.10 UCB S.A
    • 11.2.11 Sun Pharmaceutical Industries Ltd